Thus, a library of Food and Drug Administration (FDA)-approved drugs was applied to ERα-expressing ductal carcinoma cells (MCF-7), and seven compounds were found to influence the ERα content and cell proliferation [14]. The gene discussed is ESR1; the disease is breast ductal adenocarcinoma.